Tribute Pharmaceuticals is a leading Canadian specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada.
Tribute Pharmaceuticals targets several therapeutic areas in Canada, but has a particular interest in products for the treatment of pain, dermatology, urology, endocrinology and specialty care. Tribute Pharmaceuticals also sells Uracyst® and NeoVisc® internationally through a number of strategic partnerships.
Effective January 1, 2013, Stellar Pharmaceuticals Inc. (OTCQB:SLXCF) will change its name to Tribute Pharmaceuticals Canada Inc. Please visit our Investor section for more information on our company.